Videos / Real-world evidence for meningococcal B vaccines and how to have MenB conversations in general practice
In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).
Migraine Management Update
Asthma Cases – When to Use Dual vs Triple Therapy
Trauma-Informed Care in GP
Prevention and Management of Diabetic Retinopathy
expert
Consultant Paediatric Immunologist & Paediatrician; Perth Children’s Hospital; Head of the Vaccine Trials Group, Wesfarmers Centre of Vaccines and Infectious Diseases